IL322328A - אנלוגים של פפטיד דמוי גלוקגון-2 (ג'י.אל.פי) ושימושיהם הרפואיים לטיפול בתסמונת המעי הקצר (אס.בי.אס) - Google Patents

אנלוגים של פפטיד דמוי גלוקגון-2 (ג'י.אל.פי) ושימושיהם הרפואיים לטיפול בתסמונת המעי הקצר (אס.בי.אס)

Info

Publication number
IL322328A
IL322328A IL322328A IL32232825A IL322328A IL 322328 A IL322328 A IL 322328A IL 322328 A IL322328 A IL 322328A IL 32232825 A IL32232825 A IL 32232825A IL 322328 A IL322328 A IL 322328A
Authority
IL
Israel
Prior art keywords
glp
analogue
treatment
patient
peptide
Prior art date
Application number
IL322328A
Other languages
English (en)
Inventor
SVANE NIELSEN Thor SCH?TT
R?Nn Birgitte Biilmann
Graff Lykke Bjerglund
Original Assignee
Zealand Pharma As
SVANE NIELSEN Thor SCH?TT
R?Nn Birgitte Biilmann
Graff Lykke Bjerglund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As, SVANE NIELSEN Thor SCH?TT, R?Nn Birgitte Biilmann, Graff Lykke Bjerglund filed Critical Zealand Pharma As
Publication of IL322328A publication Critical patent/IL322328A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL322328A 2023-01-27 2024-01-26 אנלוגים של פפטיד דמוי גלוקגון-2 (ג'י.אל.פי) ושימושיהם הרפואיים לטיפול בתסמונת המעי הקצר (אס.בי.אס) IL322328A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23153788 2023-01-27
PCT/EP2024/051935 WO2024156884A1 (en) 2023-01-27 2024-01-26 Glucagon-like-peptide-2 (glp-2) analogues and their medical uses for the treatment of short bowel syndrome (sbs)

Publications (1)

Publication Number Publication Date
IL322328A true IL322328A (he) 2025-09-01

Family

ID=85132701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL322328A IL322328A (he) 2023-01-27 2024-01-26 אנלוגים של פפטיד דמוי גלוקגון-2 (ג'י.אל.פי) ושימושיהם הרפואיים לטיפול בתסמונת המעי הקצר (אס.בי.אס)

Country Status (8)

Country Link
EP (1) EP4654986A1 (he)
JP (1) JP2026502677A (he)
KR (1) KR20250137600A (he)
AU (1) AU2024212236A1 (he)
IL (1) IL322328A (he)
MX (1) MX2025008400A (he)
TW (1) TW202436330A (he)
WO (1) WO2024156884A1 (he)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95235C2 (en) 2005-05-04 2011-07-25 Зииланд Фарма А/С Glucagon-like-peptide-2 (glp-2) analogues
IL299864B2 (he) 2017-06-16 2024-06-01 Zealand Pharma As משטר מינון עבור ניהול גלוקגון דמוי פפטיד אנלוגי (glp–2) 2
EP3628683A1 (en) 2018-09-28 2020-04-01 Zealand Pharma A/S Formulations of glucagon-like-peptide-2 (glp-2) analogues
EP3628682A1 (en) 2018-09-28 2020-04-01 Zealand Pharma A/S Formulations of glucagon-like-peptide-2 (glp-2) analogues

Also Published As

Publication number Publication date
TW202436330A (zh) 2024-09-16
JP2026502677A (ja) 2026-01-23
WO2024156884A1 (en) 2024-08-02
AU2024212236A1 (en) 2025-08-28
MX2025008400A (es) 2025-08-01
EP4654986A1 (en) 2025-12-03
KR20250137600A (ko) 2025-09-18

Similar Documents

Publication Publication Date Title
AU2023237119B2 (en) Buffered formulations of exendin (9-39)
JP7280825B2 (ja) 肥満および関連症状の処置における使用のためのミオスタチン、アクチビンまたはアクチビン受容体アンタゴニスト
US12220444B2 (en) Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)
US9295669B2 (en) Combination therapy for proliferative disorders
EP4232151B1 (en) Use of anti-pro/latent myostatin antibody for treating spinal muscular atrophy
US20220340668A1 (en) Treatment of liver disease or disorder comprising actrii receptor antagonists
JP5197012B2 (ja) 大腸連続性を伴う短腸症候群患者の治療
TW202417035A (zh) 提派肽(tirzepatide)組合物及用途
CN110831597A (zh) 肝细胞癌的治疗
IL322328A (he) אנלוגים של פפטיד דמוי גלוקגון-2 (ג'י.אל.פי) ושימושיהם הרפואיים לטיפול בתסמונת המעי הקצר (אס.בי.אס)
CA3202157A1 (en) Use of glp-2 analogues in patients with renal insufficiency
WO2024068933A1 (en) Glucagon-like-peptide-2 (glp-2) analogues and their medical uses for the treatment of short bowel syndrome (sbs)
DK182293B1 (en) Semaglutide for use in medical therapy including weight management
WO2025073288A1 (en) Methods of treating adolescent obesity
AU2023281706A1 (en) Methods of using a gcg/glp1 co-agonist for therapy
Oke et al. British Intestinal Failure Alliance (BIFA) Position Statement Use of peptide growth factors for adult patients with intestinal failure
WO2025181330A1 (en) Dosage regimens for glucagon-like peptide 2 (glp-2) analogs
WO2025189151A1 (en) Methods and compositions for treating disorders associated with low c-peptide
WO2025189145A1 (en) Methods and compositions for treating wolfram syndrome
TW202529797A (zh) Ｇｌｐ－１類似物治療代謝疾病的方法及醫藥用途
Capsules NEW DRUG APPROVALS